mounjaro and zepbound the same - HEALTHY
Zacks Investment Research on MSN: How will Mounjaro and Zepbound sales aid LLY's upcoming Q1 results? Eli Lilly LLY has emerged as a dominant force in the cardiometabolic market, driven by strong demand for its blockbuster GLP-1 therapies, Mounjaro for type II diabetes (T2D) and Zepbound for obesity. MarketWatch: Lilly says Mounjaro and Zepbound sales more than doubled, as stock rallies Eli Lilly’s stock closed 10.3% higher on Wednesday after the drug giant reported triple-digit growth of Zepbound and Mounjaro, its game-changing weight-loss and Type 2 diabetes drugs.
Context Explanation
That’s the third ... Lilly says Mounjaro and Zepbound sales more than doubled, as stock rallies Healthline: Mounjaro, Zepbound May Lower Risk of Eye Disease in People With Diabetes Mounjaro, Zepbound May Lower Risk of Eye Disease in People With Diabetes Eli Lilly and Co. reported fourth-quarter results Wednesday that topped Wall Street expectations, with revenue of $19.3 billion — up 43% from the same quarter a year ago, driven by growth in sales of ...